Cardiac genetic disorders constitute a distinctive category of genetic anomalies affecting the heart's structure and function. These disorders encompass a spectrum of variations in the genes responsible for cardiovascular health, influencing aspects such as heart development, rhythm, and overall functionality. Some of these genetic conditions may heighten the susceptibility to congenital heart defects, while others can increase the risk of developing arrhythmias or cardiomyopathies. Unraveling the genetic underpinnings of cardiac disorders holds paramount importance, providing insights for early detection, risk evaluation, and the formulation of personalized treatment plans. Ongoing advancements in genetic testing and research contribute to a deeper comprehension of the complex interplay between genetics and cardiac well-being. This evolving understanding opens avenues for enhanced interventions and individualized strategies aimed at managing and alleviating the impact of cardiac genetic disorders.
Title : Personalized and precision medicine (PPM) as a unique healthcare model through biodesign-driven translational applications and cardiology-related healthcare marketing to secure the human healthcare and biosafety
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Beyond weight loss and diabetes control GLP 1 agonists paradigm shift in Cardiovascular care .
Syed Raza, Awali Hospital, Bahrain
Title : Vericiguat Inhibits the Progress of Cardiac Hypertrophy and Prevents Hypertrophy Induced Heart Failure by Multiple Mechanisms
Guo Wei He, TEDA International Cardiovascular Hospital, Tianjin University, China
Title : Coronary revascularization in patients with diabetes: Prospects for stenting in patients with type 1 diabetes and coronary artery disease
Mekhman N Mamedov, National Research Center for Therapy and Preventive Medicine, Russian Federation
Title : STEMI versus acute occlusive myocardial infarction: Which term should we use?
Yochai Birnbaum, Baylor College of Medicine, United States
Title : Chronic angina and the health economics of cardiovascular risk reduction in macro- and microvascular coronary disease
Uwe Peter Tigor, Auxilius Pharma, United States